FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045113956> ?p ?o ?g. }

• W3045113956 endingPage "612" @default.
• W3045113956 startingPage "604" @default.
• W3045113956 abstract "The kinase FLT3 internal tandem duplication (FLT3-ITD) is related to poor clinical outcomes of acute myeloid leukemia (AML). FLT3 inhibitors have provided novel strategies for the treatment of FLT3-ITD-positive AML. But they are limited by rapid development of acquired resistance and refractory in monotherapy. Recent evidence shows that inducing the degradation of FLT3-mutated protein is an attractive strategy for the treatment of FLT3-ITD-positive AML, especially those with FLT3 inhibitor resistance. In this study we identified Wu-5 as a novel USP10 inhibitor inducing the degradation of FLT3-mutated protein. We showed that Wu-5 selectively inhibited the viability of FLT3 inhibitor-sensitive (MV4-11, Molm13) and -resistant (MV4-11R) FLT3-ITD-positive AML cells with IC50 of 3.794, 5.056, and 8.386 μM, respectively. Wu-5 (1-10 μM) dose-dependently induced apoptosis of MV4-11, Molm13, and MV4-11R cells through the proteasome-mediated degradation of FLT3-ITD. We further demonstrated that Wu-5 directly interacted with and inactivated USP10, the deubiquitinase for FLT3-ITD in vitro (IC50 value = 8.3 µM) and in FLT3-ITD-positive AML cells. Overexpression of USP10 abrogated Wu-5-induced FLT3-ITD degradation and cell death. Also, the combined treatment of Wu-5 and crenolanib produced synergistic cell death in FLT3-ITD-positive cells via the reduction of both FLT3 and AMPKα proteins. In support of this, AMPKα inhibitor compound C synergistically enhanced the anti-leukemia effect of crenolanib, while AMPKα activator metformin inhibited the anti-leukemia effect of crenolanib. In summary, we demonstrate that Wu-5, a novel USP10 inhibitor, can overcome FLT3 inhibitor resistance and synergistically enhance the anti-AML effect of crenolanib through targeting FLT3 and AMPKα pathway." @default.
• W3045113956 created "2020-07-29" @default.
• W3045113956 creator A5010607811 @default.
• W3045113956 creator A5011233050 @default.
• W3045113956 creator A5014538185 @default.
• W3045113956 creator A5023536431 @default.
• W3045113956 creator A5029948729 @default.
• W3045113956 creator A5039030237 @default.
• W3045113956 creator A5042973046 @default.
• W3045113956 creator A5051260674 @default.
• W3045113956 creator A5052348100 @default.
• W3045113956 creator A5052689516 @default.
• W3045113956 creator A5066407348 @default.
• W3045113956 creator A5070373016 @default.
• W3045113956 creator A5071037763 @default.
• W3045113956 creator A5074978308 @default.
• W3045113956 creator A5080150992 @default.
• W3045113956 creator A5085422684 @default.
• W3045113956 date "2020-07-21" @default.
• W3045113956 modified "2023-10-05" @default.
• W3045113956 title "Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways" @default.
• W3045113956 cites W1995538310 @default.
• W3045113956 cites W2011187792 @default.
• W3045113956 cites W2017059819 @default.
• W3045113956 cites W2025510266 @default.
• W3045113956 cites W2034838691 @default.
• W3045113956 cites W2052836469 @default.
• W3045113956 cites W2080352180 @default.
• W3045113956 cites W2098264151 @default.
• W3045113956 cites W2101642059 @default.
• W3045113956 cites W2116720826 @default.
• W3045113956 cites W2136245759 @default.
• W3045113956 cites W2136710620 @default.
• W3045113956 cites W2154654162 @default.
• W3045113956 cites W2195828004 @default.
• W3045113956 cites W2254311951 @default.
• W3045113956 cites W2319422264 @default.
• W3045113956 cites W2412183643 @default.
• W3045113956 cites W2419140434 @default.
• W3045113956 cites W2559537906 @default.
• W3045113956 cites W2585860512 @default.
• W3045113956 cites W2611946404 @default.
• W3045113956 cites W2618913200 @default.
• W3045113956 cites W2754504728 @default.
• W3045113956 cites W2762414284 @default.
• W3045113956 cites W2768397451 @default.
• W3045113956 cites W2778257474 @default.
• W3045113956 cites W2791898577 @default.
• W3045113956 cites W2808682367 @default.
• W3045113956 cites W2894856132 @default.
• W3045113956 cites W2900888512 @default.
• W3045113956 cites W2909346948 @default.
• W3045113956 cites W2928770604 @default.
• W3045113956 cites W2935568878 @default.
• W3045113956 cites W2938284866 @default.
• W3045113956 cites W2938931338 @default.
• W3045113956 cites W2954718362 @default.
• W3045113956 cites W2969169462 @default.
• W3045113956 cites W2972190030 @default.
• W3045113956 cites W2994243335 @default.
• W3045113956 doi "https://doi.org/10.1038/s41401-020-0455-x" @default.
• W3045113956 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8115260" @default.
• W3045113956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32694757" @default.
• W3045113956 hasPublicationYear "2020" @default.
• W3045113956 type Work @default.
• W3045113956 sameAs 3045113956 @default.
• W3045113956 citedByCount "14" @default.
• W3045113956 countsByYear W30451139562021 @default.
• W3045113956 countsByYear W30451139562022 @default.
• W3045113956 countsByYear W30451139562023 @default.
• W3045113956 crossrefType "journal-article" @default.
• W3045113956 hasAuthorship W3045113956A5010607811 @default.
• W3045113956 hasAuthorship W3045113956A5011233050 @default.
• W3045113956 hasAuthorship W3045113956A5014538185 @default.
• W3045113956 hasAuthorship W3045113956A5023536431 @default.
• W3045113956 hasAuthorship W3045113956A5029948729 @default.
• W3045113956 hasAuthorship W3045113956A5039030237 @default.
• W3045113956 hasAuthorship W3045113956A5042973046 @default.
• W3045113956 hasAuthorship W3045113956A5051260674 @default.
• W3045113956 hasAuthorship W3045113956A5052348100 @default.
• W3045113956 hasAuthorship W3045113956A5052689516 @default.
• W3045113956 hasAuthorship W3045113956A5066407348 @default.
• W3045113956 hasAuthorship W3045113956A5070373016 @default.
• W3045113956 hasAuthorship W3045113956A5071037763 @default.
• W3045113956 hasAuthorship W3045113956A5074978308 @default.
• W3045113956 hasAuthorship W3045113956A5080150992 @default.
• W3045113956 hasAuthorship W3045113956A5085422684 @default.
• W3045113956 hasBestOaLocation W30451139561 @default.
• W3045113956 hasConcept C104317684 @default.
• W3045113956 hasConcept C184235292 @default.
• W3045113956 hasConcept C185592680 @default.
• W3045113956 hasConcept C190283241 @default.
• W3045113956 hasConcept C2778729363 @default.
• W3045113956 hasConcept C2780124434 @default.
• W3045113956 hasConcept C2910954276 @default.
• W3045113956 hasConcept C31573885 @default.
• W3045113956 hasConcept C33195913 @default.
• W3045113956 hasConcept C501734568 @default.

• next